ENTITY

REGENXBIO Inc (RGNX US)

27
Analysis
Health CareUnited States
REGENXBIO Inc. operates as a biotechnology company. The Company focuses on the development, commercialization, and licensing of recombinant, and adeno-associated virus gene therapy. REGENXBIO serves customers worldwide.
more
09 Dec 2024 12:05

S&P500/400/600 Index Rebalance: Apollo Global, Workday Added to SPX; AppLovin Misses Out

There are 2 changes for SnP500, 2 for SnP400 and 6 for SnP600. The outright adds are up big in the after-hours market. There will be more flows for...

Logo
419 Views
Share
05 Dec 2024 18:16

Quiddity Leaderboard S&P 500 Dec 24 Rebal - Final Predictions

The S&P500/400/600 rebal data "fixed" on 4 Dec open. The announcement will be made post-close 6 Dec. Applovin is up 900% in a year and is a top...

Logo
1.1k Views
Share
20 Nov 2024 18:27

Quiddity Leaderboard S&P 500 Dec 24: APP, APO, and TPL May Be ADDs, Watch SP600 DELs

The S&P500/400/600 Dec24 review will be announced in just over 10 days. There is an intra-review change in SP600 first, and perhaps a few more in...

Logo
331 Views
Share
29 Oct 2024 18:54

Quiddity Leaderboard S&P 500 Dec 24 Rebal: APO, CRH, WDAY, TPL

The S&P500 rebalance in December is shaping up to be a trade worth $8-13bn a side but there is a possible intra-review change to come as well....

Logo
375 Views
Share
bullishS&P 500 INDEX
10 Aug 2022 06:18

S&P 500, Nasdaq 100 Testing Key Resistance Levels; Pause Likely; Buying Biotech

$SPX is testing important resistance in the 4165-4180 area, the same resistance level we were monitoring in early June before the market tumbled 13...

Logo
325 Views
Share
x